NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637905. A total of 2 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $57,000 | -36.0% | 1,070 | -19.3% | 0.00% | – |
| Q2 2020 | $89,000 | +85.4% | 1,326 | +57.5% | 0.00% | – |
| Q1 2020 | $48,000 | +1100.0% | 842 | +2531.2% | 0.00% | – |
| Q4 2019 | $4,000 | -95.7% | 32 | -93.1% | 0.00% | – |
| Q3 2019 | $93,000 | +165.7% | 467 | +222.1% | 0.00% | – |
| Q2 2019 | $35,000 | +40.0% | 145 | +36.8% | 0.00% | – |
| Q1 2019 | $25,000 | +2400.0% | 106 | +2020.0% | 0.00% | – |
| Q3 2018 | $1,000 | -98.9% | 5 | -98.0% | 0.00% | – |
| Q2 2018 | $88,000 | – | 255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 500 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |